Pea protein peptides with anti Helicobacter pylori activity

Patent metadata

Field	Value
Publication number	US-9603888-B2
Application number	US-201514637057-A
Country	US
Kind code	B2
Filing date	Mar 3, 2015
Priority date	Mar 29, 2010
Publication date	Mar 28, 2017
Grant date	Mar 28, 2017

Abstract

The invention relates to a composition comprising pea protein hydrolysate for the treatment and/or prevention of infection by gastrointestinal pathogens, in particular Helicobacter pylori and/or a disease associated with infection by said gastrointestinal pathogen in mammals.

First claim

The invention claimed is:

1. A composition comprising a lipid, protein and carbohydrate constituent, wherein the lipid constituent provides 5 to 50% of the total calories, the protein constituent provides 5 to 50% of the total calories and the carbohydrate constituent provides 15 to 90% of the total calories, wherein the protein constituent comprises:
(i) at least one protein source consisting of pea protein hydrolysate, wherein the pea protein hydrolysate is obtained by hydrolysis with a protease in the absence of chymotrypsin and wherein the pea protein hydrolysate comprises over 35 wt % peptides with a size between 1 and 2.5 kDa based on total weight of the pea protein hydrolysate, and
(ii) at least one nitrogen source selected from the group consisting of milk proteins, milk protein hydrolysate, egg proteins, egg protein hydrolysate, soy protein, soy protein hydrolysate, wheat protein, wheat protein hydrolysate, rice protein, rice protein hydrolysate, free amino acids and mixtures thereof.

2. The composition according to claim 1 , comprising at least one selected from the group consisting of hydrolysed cow's whey, non-hydrolysed cow's whey, hydrolysed cow's casein, non-hydrolysed cow's casein, hydrolysed soy protein and non-hydrolysed soy protein.

3. The composition according to claim 1 , comprising a soluble, non-digestible, fermentable oligosaccharide.

4. The composition according to claim 1 , having an osmolality between 50 and 500 mOsm/kg.

5. The composition according to claim 1 , in the form of a nutritional or pharmaceutical composition.

6. The composition according to claim 1 , wherein the pea protein hydrolysate comprises a peptide selected from the group consisting of Xaan-Asp-Phe-Leu-Glu-Asp-Ala-Phe-Asn-Val-Asn-Arg-Xaam (SEQ ID NO: 14) and Xaan-Glu-Leu-Ala-Phe-Pro-Gly-Ser-Ala-Gln-Glu-Val-Asp-Arg-Xaam (SEQ ID NO: 15), wherein each Xaa independently can be any amino acid and n and m are integers independently ranging from 0-10.

7. A composition comprising a lipid, protein and carbohydrate constituent wherein the lipid constituent provides 5 to 50% of the total calories, the protein constituent provides 5 to 50% of the total calories and the carbohydrate constituent provides 15 to 90% of the total calories, wherein the protein constituent comprises:
(i) at least one protein source consisting of peptides selected from the group consisting of Xaan-Asp-Phe-Leu-Glu-Asp-Ala-Phe-Asn-Val-Asn-Arg-Xaam (SEQ ID NO: 14) and Xaan-Glu-Leu-Ala-Phe-Pro-Gly-Ser-Ala-Gln-Glu-Val-Asp-Arg-Xaam (SEQ ID NO: 15), wherein each Xaa independently can be any amino acid and n and m are integers independently ranging from 0-10, and
(ii) at least one nitrogen source selected from the group consisting of milk proteins, milk protein hydrolysate, egg proteins, egg protein hydrolysate, soy protein, soy protein hydrolysate, wheat protein, wheat protein hydrolysate, rice protein, rice protein hydrolysate, free amino acids and mixtures thereof.

8. A composition comprising a non-digestible oligosaccharide selected from the group consisting of trans-galactooligosaccharide, fructo-oligosaccharides, uronic acid oligosaccharide and sialyllactose and
(a) pea protein hydrolysate, which is obtained by hydrolysis with protease other than chymotrypsin, wherein the pea protein hydrolysate comprises over 35 wt % peptides with a size between 1 and 2.5 kDa based on total weight of the pea protein hydrolysate; and/or
(b) at least one peptide selected from the group consisting of Xaan-Asp-Phe-Leu-Glu-Asp-Ala-Phe-Asn-Val-Asn-Arg-Xaam (SEQ ID NO: 14) and Xaan-Glu-Leu-Ala-Phe-Pro-Gly-Ser-Ala-Gln-Glu-Val-Asp-Arg-Xaam (SEQ ID NO: 15), wherein each Xaa independently can be any amino acid and n and m are integers independently ranging from 0-10.

Assignees

• Nutricia Nv

Inventors

• Georgi Gilda Elise
• Euler Marco
• Mank Marko
• Hensel Andreas
• Niehues Michael
• Klapperich Monika
• Stahl Bernd

Classifications

• A61P31/04

  Antibacterial agents · CPC title

• A61P1/00

  Drugs for disorders of the alimentary tract or the digestive system · CPC title

• A61P1/04

  for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title

• C07K14/415

  from plants · CPC title

• A61K38/08

  Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title